Literature DB >> 26711630

Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Martin Söderholm1,2, Malin Inghammar3, Bo Hedblad4, Arne Egesten5, Gunnar Engström4.   

Abstract

It is uncertain whether the incidence of stroke is increased in patients with chronic obstructive pulmonary disease (COPD), and whether COPD is associated with all subtypes of stroke (i.e. ischemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage). We evaluated the association between COPD and incidence of stroke in a nation-wide cohort study. All individuals between 40 and 84 years of age, hospitalised for COPD between 1987 and 2003 in Sweden were identified in the Swedish hospital discharge register. For each COPD patient (n = 103,419), one reference individual was randomly selected from the general population matched for year of birth, sex and county of residence. After excluding subjects with prior stroke, incidence rates during 10 years follow-up were calculated. Hazard ratios (HR) for stroke comparing COPD patients with reference subjects were estimated using Cox regression adjusting for demographics and comorbidities. Incidence of all-cause stroke (n events = 17,402) was significantly increased in COPD patients compared to reference individuals (HR 1.24, 95 % CI 1.19-1.28), especially during the first 2 years after COPD diagnosis (HR 1.46, 1.37-1.55). Incidences of ischemic stroke (HR 1.20, 1.15-1.25), intracerebral haemorrhage (HR 1.29, 1.16-1.43) and subarachnoid haemorrhage (HR 1.46, 1.16-1.85) were all increased in COPD patients. Incidences of all stroke subtypes are increased in COPD, especially during the first years after COPD diagnosis. The association was independent of several comorbidities, although residual confounding from smoking and hypertension cannot be excluded. A global evaluation of stroke risk factors seems warranted in patients with COPD.

Entities:  

Keywords:  COPD; Cerebral infarction; Intracerebral haemorrhage; Stroke; Subarachnoid haemorrhage

Mesh:

Year:  2015        PMID: 26711630     DOI: 10.1007/s10654-015-0113-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  39 in total

1.  Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study.

Authors:  E Zia; O Melander; H Björkbacka; B Hedblad; G Engström
Journal:  J Intern Med       Date:  2012-03-19       Impact factor: 8.989

2.  Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers.

Authors:  J Merlo; U Lindblad; H Pessah-Rasmussen; B Hedblad; J Rastam; S O Isacsson; L Janzon; L Råstam
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

3.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

4.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

5.  Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study.

Authors:  Andrea S Gershon; Laura Warner; Paul Cascagnette; J Charles Victor; Teresa To
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

6.  Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000.

Authors:  R Montnémery; U Nihlén; M Andersson; L Greiff; A Johannisson; P Nyberg; C G A Persson; C G Löfdahl
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

7.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

8.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

9.  Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.

Authors:  A K Johnston; D M Mannino; G W Hagan; K J Davis; V A Kiri
Journal:  Thorax       Date:  2008-02-01       Impact factor: 9.139

10.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

View more
  12 in total

1.  Hck Promotes Neuronal Apoptosis Following Intracerebral Hemorrhage.

Authors:  Jun Wang; Rongrong Chen; Xiaojuan Liu; Jianhong Shen; Yaohua Yan; Yilu Gao; Tao Tao; Jiansheng Shi
Journal:  Cell Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.046

2.  Emphysema: A Potential Risk Factor for Subarachnoid Hemorrhage and Ruptured Aortic Aneurysm

Authors:  Ali Mahta; Alexander E Merkler; Michael E Reznik; Jaclyn E Burch; Shadi Yaghi; Frank W Sellke; Karen L Furie; Hooman Kamel
Journal:  Stroke       Date:  2019-04       Impact factor: 7.914

3.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

Review 4.  Chronic Obstructive Pulmonary Disease and the Risk of Stroke.

Authors:  Ann D Morgan; Chetna Sharma; Kieran J Rothnie; James Potts; Liam Smeeth; Jennifer K Quint
Journal:  Ann Am Thorac Soc       Date:  2017-05

5.  O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity.

Authors:  Rongrong Chen; Peipei Gong; Tao Tao; Yilu Gao; Jianhong Shen; Yaohua Yan; Chengwei Duan; Jun Wang; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2017-02-25       Impact factor: 5.046

6.  Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Chao-Shun Lin; Chun-Chuan Shih; Chun-Chieh Yeh; Chaur-Jong Hu; Chi-Li Chung; Ta-Liang Chen; Chien-Chang Liao
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 7.  Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis.

Authors:  Hong-Lei Yin; Shi-Qi Yin; Qing-Yan Lin; Ying Xu; Hong-Wei Xu; Tao Liu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

8.  Long-Term Mortality and Medical Burden of Patients with Chronic Obstructive Pulmonary Disease with and without Subsequent Stroke Episodes.

Authors:  Yu-Shu Yen; Dorji Harnod; Cheng-Li Lin; Tomor Harnod; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2020-04-08       Impact factor: 3.390

9.  Neurological and Psychiatric Comorbidities in Chronic Obstructive Pulmonary Disease.

Authors:  Kristijonas Puteikis; Rūta Mameniškienė; Elena Jurevičienė
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-03

Review 10.  Stroke risk among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Authors:  Yu Ree Kim; In Cheol Hwang; Yong Joo Lee; Eun Bee Ham; Dong Kyun Park; Sewan Kim
Journal:  Clinics (Sao Paulo)       Date:  2018-05-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.